What We're Reading: Page 48
Industry reads hand-picked by our editors
Jul 02, 2024
Jul 01, 2024
-
Science News
Supreme Court ruling may threaten role of science in U.S. rulemaking
-
Fierce Pharma
Pfizer poaches Novartis exec as oncology commercial chief
-
Financial Times
Swiss buyout firm Partners Group lands deal for stake in €900mn biotech firm
-
Axios
“New era” of cosmetics’ regulation: FDA wields new powers over makeup companies
Jun 28, 2024
-
NPR
Health insurers cover fewer drugs and make them harder to get
-
Associated Press
As COVID-19 ticks up in some places, US health officials recommend a fall vaccination campaign
-
Reuters
Drugmaker Servier loses EU court fight over pay-for-delay deals
-
The Financial Times
To cure disease, AI needs more of our data
Jun 27, 2024
-
AP News
The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma
-
Reuters
US FDA approves Verona Pharma’s inhaled COPD therapy
-
Hunterbrook Media
Hims & Hers Selling GLP-1 Injection That’s Not FDA Approved, From Shady Supplier — And Won’t Make You Talk to a Doctor to Get It
Jun 26, 2024
Jun 25, 2024
-
Financial Times
Novo Nordisk weight loss drug Wegovy approved in China
-
BioCentury
FDA’s different Peter principle problem: poorly articulated, idiosyncratic decision-making
-
Bloomberg
A Brain Cancer Treatment for Kids Started with Family Fundraisers
-
MIT Technology Review
Is this the end of animal testing?
Jun 24, 2024
-
AP News
Gene therapy may cure rare diseases. But drugmakers have few incentives, leaving families desperate
-
PMLive
Bristol Myers Squibb’s Krazati granted FDA accelerated approval in colorectal cancer
-
C&EN
Macrocyclic peptides: Aiming for the perfect fit
-
Axios
How the health system is trying to improve postpartum care
Previous
